Press Releases

Archive

October 2, 2026

Press Release

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement

October 1, 2026

Press Release

AIML Subsidiary NeuralCloud Signs Binding Commercial Term Sheet with VetMed Consultants for MaxYield™ ECG Services

September 29, 2026

Press Release

AIML Subsidiary NeuralCloud Enters Strategic Partnership with RKS Medical Technologies to Advance CardioYield™ Clinical Pilots

September 21, 2026

Press Release

AI/ML Innovations Launches Quantum Soma Initiative with Dynex Quantum Technologies for Contactless Quantum Biosensing Platform

September 1, 2026

Press Release

AI/ML Innovations subsidiary NeuralCloud Appoints Former FDA Reviewer Dr. Mehmet Kosoglu as the Head of Regulatory Affairs

August 26, 2026

Press Release

AI/ML Innovations Inc. Closes First Tranche of Private Placement

August 18, 2026

Press Release

AIML Subsidiary NeuralCloud Signs Term Sheet with Island Mobile Cardiology Testing for CardioYield™ Pilot

August 14, 2026

Press Release

AI/ML Innovations Inc. Announces Proposed Private Placement

August 11, 2026

Press Release

AI/ML Innovations’ Subsidiary NeuralCloud Achieves ISO 13485:2016 (MDSAP) Certification

June 23, 2026

Press Release

AI/ML Innovations Inc. Announces Grant of U.S. Patent Expanding Protection for AI-Driven ECG Analysis

June 1, 2026

Press Release

AIML Subsidiary NeuralCloud Appoints Cardiac Monitoring Veterans Dale and Nicholas DuBois to Lead Clinical and Overread Operations

May 11, 2026

Press Release

AIML Appoints Dr. Martin Green to Medical Advisory Board and Issue Options

March 31, 2026

Press Release

Neural Cloud Signs Reseller Agreement with European Digital Cardiac Monitoring Platform

March 27, 2026

Press Release

AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000

March 25, 2026

Press Release

AIML Subsidiary NeuralCloud Enters Research Services Agreement with Baker Heart and Diabetes Institute to Support AI-Driven ECG Analysis

March 12, 2026

Press Release

AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures

February 24, 2026

Press Release

Neural Cloud Enters Distribution Agreement with Intelimed to Expand into Latin America

February 12, 2026

Press Release

AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting

February 10, 2026

Press Release

Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion

January 28, 2026

Press Release

AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board

January 20, 2026

Press Release

AIML subsidiary NeuralCloud Collaborates with Movesense to Expand Bundled ECG Solutions for Clinical and Wellness Markets

January 8, 2026

Press Release

AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield™ for AI-Powered Holter Analysis

January 7, 2026

Press Release

AIML Appoints Erik Suokas as Chief Operating Officer to Accelerate Commercial Execution and Operational Scale

December 30, 2025

Press Release

AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer

December 16, 2025

Press Release

Join AIML’s Live Shareholder Update with Chairman & CEO Paul Duffy

December 9, 2025

Press Release

AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield™ and Insight360™ into INTRINSICA's DNA-Guided Biofeedback Wellness Ecosystem

December 2, 2025

Press Release

AIML subsidiary NeuralCloud Enters Pilot with Cornerstone Physiotherapy to Deploy MaxYield™ and Insight360™ for Elite Athlete Cardiac Performance Testing

November 26, 2025

Press Release

AIML subsidiary NeuralCloud Signs Commercial Term Sheet with Equimetrics to Deploy MaxYield™ and CardioYield™ across Equine Cardiac Monitoring Platforms

November 24, 2025

Press Release

AIML subsidiary Neural Cloud begins pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care

November 11, 2025

Press Release

AI/ML Innovations Inc. Announces Grant of U.S. Patent Protecting Core ECG Signal-Processing Architecture

November 4, 2025

Press Release

AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants to Lead Regulatory Submission for CardioYield™ in Jamaica

October 21, 2025

Press Release

AIML Subsidiary NeuralCloud Solutions Commencing Pilot with Canadian Cardiology Clinic to Advance AI-Powered ECG Reporting

October 15, 2025

Press Release

AIML Subsidiary NeuralCloud Solutions and Heartdent Center Ltd. Launch Pilot Project to Advance Cardiac Care in Jamaica

October 7, 2025

Press Release

AIML Subsidiary NeuralCloud Solutions and Toronto Heart Centre Launch a Pilot Program to Test AI-Powered Holter ECG Reporting

September 30, 2025

Press Release

AIML and BC Brain Wellness Program Launch Pilot to Explore the Heart–Brain Connection

September 22, 2025

Press Release

AIML Announces Closing of Oversubscribed Private Placement

September 4, 2025

Press Release

AIML Announces Proposed Private Placement

August 21, 2025

Press Release

AIML Announces SEDAR Filing

August 8, 2025

Press Release

AIML Innovations Closes Quantum Sciences Ltd. Restructuring

June 10, 2025

Press Release

AIML Strengthens IP Portfolio with Provisional Patents for AI Driven ECG Signal Processing

June 3, 2025

Press Release

AIML Subsidiary Neural Cloud Signs LOI with Circular Health to License MaxYield™ ECG Signal-Processing

May 22, 2025

Press Release

AIML Establishes Innovation Committee, Appoints Dr. Drew Dundas as Chair

May 20, 2025

Press Release

AIML Establishes Medical Advisory Board to Drive AI Powered ECG Signal Processing Innovation

May 15, 2025

Press Release

AIML Hits Key Regulatory Benchmark with 510(k) Filing for MaxYield™ Signal Enhancement Platform

May 5, 2025

Press Release

AIML Innovations Appoints Political Strategist and Public Affairs Leader, Michael Diamond, to Board of Directors

April 25, 2025

Press Release

AIML Innovations Announces Departure of Tim Daniels from Board of Directors

April 25, 2025

Press Release

AIML Optimizes Quantum Sciences Acquisition to Drive Growth & Strategic Focus

April 22, 2025

Press Release

AIML Innovations Appoints Jared Adelstein to Board of Directors

April 15, 2025

Press Release

AIML Announces Closing of Oversubscribed Private Placement

April 7, 2025

Press Release

AIML Updates Terms of Proposed Private Placement Announced

April 4, 2025

Press Release

AIML Announces Proposed Private Placement

March 21, 2025

Press Release

AIML Continues to Streamline for the Future and Moves Beyond Tech2Heal

March 14, 2025

Press Release

AIML Aligns Leadership for Growth and Shareholder Value Creation

February 20, 2025

Press Release

Key Updates to Upcoming Annual and Special Meeting

January 28, 2025

Press Release

Andrea Ruth Joins AI/ML Innovations as Head of Quality, Clinical, and Regulatory Affairs

January 23, 2025

Press Release

AI/ML Innovations Inc. Appoints Dr. Alan Rabinowitz as Chief Medical Officer and Director of Medical Partnerships

January 9, 2025

Press Release

AI/ML Innovations Inc. Welcomes Industry Trailblazers to Board of Directors

Earlier releases

February 21, 2025

ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

February 21, 2025

Annual General & Special Meeting to be held on Friday, February 21, 2025

February 21, 2025

NOTICE AND ACCESS NOTIFICATION TO SHAREHOLDERS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

January 27, 2025

AI/ML Innovations Inc. Appoints Dr. Alan Rabinowitz as Chief Medical Officer and Director of Medical Partnerships

January 9, 2025

AI/ML Innovations Inc. Welcomes Industry Veterans to Board of Directors

January 6, 2025

AI/ML Innovations Inc. Announces Appointment of Peter Kendall as President and Chief Commercialization Officer

December 24, 2024

AI/ML INNOVATIONS CLOSES ACQUISITION OF QUANTUM SCIENCES LTD.

December 11, 2024

AI/ML Innovations Inc. Completes Shares for Debt Arrangement

December 10, 2024

AI/ML INNOVATIONS TO ACQUIRE QUANTUM SCIENCES LTD.

December 3, 2024

AI/ML Innovations Inc. Announces New Chief Financial Officer and Corporate Secretary; Enters Debt Settlement Arrangement

November 26, 2024

AI/ML Innovations Inc. Announces Final Private Placement Closing

November 1, 2024

AI/ML Innovations Inc. Announces Initial Private Placement Closing

October 28, 2024

AI/ML Innovations Inc. Increases Proposed Private Placement

October 21, 2024

AI/ML Innovations Inc. Announces Proposed Private Placement

October 11, 2024

AI/ML Innovations Announces Board Resignation

October 10, 2024

AI/ML Innovations Inc. Announces Impairment of Investment

October 2, 2024

AI/ML Innovations Inc. Announces Revocation of MCTO

September 20, 2024

AI/ML Innovations Inc. Provides Second Status Update

September 6, 2024

AI/ML Innovations Inc. Provides Status Update

August 29, 2024

AI/ML Innovations Inc. Granted Management Cease Trade Order

August 23, 2024

AI/ML Innovations Inc. Completes Acquisition of Technology from Naiad Lab Inc.

August 23, 2024

AI/ML Innovations Inc. Announces Late Filing of Annual Financial Disclosure

August 19, 2024

AI/ML Innovations Inc. Announces Closing of Financing

August 15, 2024

AI/ML Innovations Inc. Announces Settlement of Debt with ThreeD Capital Inc.

August 9, 2024

AI/ML Innovations Inc. Announces Proposed Private Placement

July 17, 2024

AI/ML Innovations Inc. Announces Closing of Financing

July 9, 2024

AI/ML Innovations Inc. Announces Upcoming Webinar

July 2, 2024

AI/ML Innovations Inc. Announces First Closing of Financing

June 21, 2024

AI/ML Innovations Inc. Announces Proposed Private Placement

June 19, 2024

AI/ML Innovations Inc. Launches TheNeuralCloud.com, a Neural Net as a Service Platform

June 17, 2024

AI/ML Innovations Inc. Completes Acquisition of Technology from Naiad Lab Inc.

June 14, 2024

AI/ML Innovations Inc. Announces Shares for Debt Transaction

May 28, 2024

AI/ML Innovations Inc. Introduces “The Neural Net Store”

May 17, 2024

AI/ML Innovations Inc. Announces Agreement with Moonshot Inc.

May 16, 2024

AI/ML Innovations Inc. Introduces NeuralCloud Solutions Incorporated, its Newest Operating Subsidiary

May 6, 2024

AI/ML Innovations Inc. Introduces its Proprietary “Long ECG Neural Network”

May 2, 2024

AI/ML Innovations Inc. Enters Binding Letter of Intent to Acquire Strategic Neural Net Healthcare Assets

April 10, 2024

AI/ML Innovations Inc. Chosen for Healthcare Micro Payment Integration Utilizing TodaQ MicroPay Technology

April 4, 2024

AI/ML Innovations Inc. Announces Upcoming Townhall

April 2, 2024

TODAQ Micro C:AIML ThingyAI™ DoTalk™ Launch Micropayments and AI Conversational Checkout

March 13, 2024

AI/ML Innovations Inc.’s Health Gauge Unveils ‘The Pulse Guru’, its Second Advanced Neural Network Based Commercial Product

March 11, 2024

AI/ML Innovations Inc. Announces Settlement of Debt with ThreeD Capital Inc.

March 6, 2024

AI/ML Innovations Inc.’sHealth Gauge Launches "Follow Your Heart": A Revolutionary Non-Invasive Blood Pressure Measurement Solution

March 4, 2024

AI/ML Innovations Inc. Welcomes Esmat Naikyar as Interim Chief Product Officer to Drive Healthcare Innovation

February 27, 2024

AI/ML Innovations Inc.’s Health Gauge Seeking FDA Approval for its Patented Blood Pressure Measurement Technology

February 14, 2024

AI/ML Innovations Inc. Appoints Dr. David Cramb, Dean of the Faculty of Science at Toronto Metropolitan University, as Chair of the Company’s Inaugural Science and Product Advisory Board

February 8, 2024

AI/ML Innovations Inc. Presents A Fireside Chat and a Company Update

February 6, 2024

AI/ML Innovations Inc. Unveils Micropayment Pilot Program in Collaboration with TODAQ Micro and Health Gauge Biometrics

January 23, 2024

AI/ML Innovations Inc.’s Subsidiary, Health Gauge, Unveils Its Proprietary “The Pulse Whisperer” for Biometric Raw Signal Data to Empower Life Science Researchers

January 17, 2024

AI/ML Innovations Inc.’s Subsidiary, Health Gauge, and Cornerstone Physiotherapy Partner to Implement Canada's First Telehealth Program for Long Covid Rehabilitation Enabled by Advanced Biometrics

January 12, 2024

AI/ML Innovations Inc. Announces Settlement of Debt with Octagon Media Inc.

January 9, 2024

AI/ML Innovations Inc. Announces Upcoming Townhall

December 18, 2023

AI/ML Innovations Inc. Closes Private Placement

December 11, 2023

AI/ML Innovations Inc. Terminates Investor Relations Appointment

December 8, 2023

AI/ML Innovations Inc. Enters Market Awareness Agreement

December 8, 2023

AI/ML Innovations Inc. Enters Market Awareness Agreement

December 7, 2023

AI/ML Innovations Inc. Announces Closing of Private Placement

December 1, 2023

AI/ML Innovations Inc. Grants Stock Options

November 21, 2023

AI/ML Innovations Inc. Announces Annual General Meeting Results

November 9, 2023

AI/ML Innovations Inc.’s Subsidiary Announces Strategic Partnership with a Leader in Virtual Occupational Health Clinics

November 1, 2023

AI/ML Innovations Inc., Advancing AI+AR Smart Glasses for Trillion Dollar Global Healthcare Markets

October 19, 2023

AI/ML Innovations Inc.’s Subsidiary Enters Consortium with Essilor International for AI-powered Augmented Reality Eyewear Project

October 11, 2023

AI/ML Innovations Inc. Announces Settlement of Debt

October 4, 2023

AI/ML Innovations Inc.’s Subsidiary Receives Funding Grant for Its Participation in Europe’s Largest Study for the Prevention of Loss of Autonomy in the Elderly

September 29, 2023

NEWS RELEASE – for immediate release

September 21, 2023

AI/ML Innovations Inc. Announces Change to Board of Directors

September 11, 2023

Industry Expert Paul Duffy Takes the Helm as CEO of AI/ML Innovations Inc.

August 18, 2023

AI/ML Innovations Inc. Announces Option Grant and IR Agreement Restructuring

August 3, 2023

AI/ML Innovations AI-Powered Digital Health Platform Accelerating Momentum in Global Markets

July 31, 2023

AI/ML Innovations Inc. Announces Investor Relations Appointment

July 12, 2023

AI/ML Innovations Inc’s Subsidiary Revolutionizes Digital Health Platforms with AI Automation Enhancements

July 12, 2023

AI/ML Innovations Inc. Closes Oversubscribed Private Placement

July 7, 2023

AI/ML Innovations Inc. Announces Closing of Proposed Private Placement

June 30, 2023

AI/ML Innovations Inc. Announces Closing of Second Tranche of Private Placement

June 16, 2023

AI/ML Innovations Inc. Announces Proposed Private Placement

June 14, 2023

AI/ML Innovations’ AI-driven, Patented Technology is Chosen for University of Alberta Respiratory Disease Clinical Study

June 13, 2023

AI/ML Innovations Inc. Updates Closing of First Tranche of Private Placement

June 6, 2023

AI/ML Innovations Inc. Announces Closing of First Tranche of Proposed Private Placement

May 26, 2023

AI/ML Innovations Inc. Announces Strategic Agreement with World Weight Loss, Inc. to Develop an AI-powered Weight Loss Avatar and App

April 28, 2023

AI/ML Innovations Inc. Announces Interim CFO

April 11, 2023

AI/ML Innovations Introduces “Health Coach” - a Personalized AI- powered Health Advisor

March 28, 2023

AI/ML Innovations’ Tech2Heal Chosen for Europe’s Largest Study for the Prevention of Loss of Autonomy in the Elderly

March 22, 2023

AI/ML Innovations Engages Frontier Flex Marketing for Market Awareness and Grants Stock Options

March 15, 2023

AI/ML Innovations Inc. Announces Update to Closing of Financing

March 14, 2023

AI/ML Innovations Inc. Announces Closing of Financing

March 6, 2023

AI/ML Innovations’ Health Gauge Concludes Successful Blood Pressure Validation Study on its AI-Powered Health Monitoring Solution

February 2, 2023

AI/ML Innovations’ Tech2Heal Wins Prestigious Innovation Grand Prize Award

January 24, 2023

AI/ML Innovations Inc. Announces Successful Closing of the Warrant Repricing and Early Warrant Exercise Incentive Program

January 12, 2023

AI/ML Innovations’ Tech2Heal Launches Its Remote Patient Care Platform

January 12, 2023

AI/ML Innovations Inc. Announces Successful Closing of the Warrant Repricing and Early Warrant Exercise Incentive Program

January 4, 2023

AI/ML Innovations’ Health Gauge to Investigate Potential Patent Infringement Enforcement

December 29, 2022

AI/ML Innovations Engages Octagon Media/Wall Street Reporter for Market Awareness

December 16, 2022

AI/ML Innovations Inc. Announces Warrant Repricing and Early Warrant Exercise Incentive Program

November 14, 2022

AI/ML INNOVATIONS ACQUIRES FULL OWNERSHIP OF DIGITAL HEALTHCARE COMPANY, HEALTH GAUGE INC.

November 4, 2022

AI/ML Innovations Inc. Announces Revocation of MCTO

October 25, 2022

AI/ML Innovations Inc. Provides Fourth Status Update

October 11, 2022

AI/ML Innovations Inc. Provides Third Status Update

September 27, 2022

AI/ML Innovations Inc. Provides Second Status Update

September 13, 2022

AI/ML Innovations Inc. Provides Status Update

August 30, 2022

AI/ML Innovations Inc. Granted Management Cease Trade Order